Abstract

In this study, we show that calcium pectinate beads (CPB) allow the formation of 20 µm spherical microcolonies of the probiotic bacteria Lacticaseibacillus paracasei (formerly designated as Lactobacillus paracasei) ATCC334 with a high cell density, reaching more than 10 log (CFU/g). The bacteria within these microcolonies are well structured and adhere to a three-dimensional network made of calcium-pectinate through the synthesis of extracellular polymeric substances (EPS) and thus display a biofilm-like phenotype, an attractive property for their use as probiotics. During bacterial development in the CPB, a coalescence phenomenon arises between neighboring microcolonies accompanied by their peripheral spatialization within the bead. Moreover, the cells of L. paracasei ATCC334 encased in these pectinate beads exhibit increased resistance to acidic stress (pH 1.5), osmotic stress (4.5 M NaCl), the freeze-drying process and combined stresses, simulating the harsh conditions encountered in the gastrointestinal (GI) tract. In vivo, the oral administration of CPB-formulated L. paracasei ATCC334 in mice demonstrated that biofilm-like microcolonies are successfully released from the CPB matrix in the colonic environment. In addition, these CPB-formulated probiotic bacteria display the ability to reduce the severity of a DSS-induced colitis mouse model, with a decrease in colonic mucosal injuries, less inflammation, and reduced weight loss compared to DSS control mice. To conclude, this work paves the way for a new form of probiotic administration in the form of biofilm-like microcolonies with enhanced functionalities.

Highlights

  • The human gut harbors a complex ecosystem composed of 1013–14 microorganisms

  • Development of biofilm-like microcolonies encapsulated in calcium-pectinate beads

  • We investigated the ability of L. paracasei ATCC334 to develop biofilm inside calcium-pectinate beads (CPB)

Read more

Summary

Introduction

Non-pathogenic commensal microbiota is necessary for normal gastrointestinal (GI) physiology. The World Health Organization (WHO) has defined probiotics as ‘live microorganisms which, when administered in adequate amounts confer a health benefit on the host’[1]. Probiotic bacteria, which are administered orally, have to cope with the adverse conditions encountered in the GI tract and their release must be controlled to ensure maximum effectiveness[4,5]. Due to their non-toxicity, biocompatibility, and low cost, polysaccharides such as alginate and pectin are used to encapsulate probiotics[6]. Pectin is a polysaccharide rich in D-galacturonic acid and contains significant amounts of neutral sugars such as D-xylose, D-glucose, L-rhamnose, L-arabinose, and

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call